Article
Ferroptosis vulnerability in FLT3-mutant leukemia.
Trends in cancer - 1 Jul 2023
Lee Hyemin, Zhuang Li, Gan Boyi
Abstract excerpt
Resistance to FLT3 inhibition is a prevalent challenge in managing FLT3-mutant acute myeloid leukemia (AML). A recent study by Sabatier et al. discovered ferroptosis vulnerability in FLT3-mutant AML and they propose a promising therapeutic approach of combining FLT3 inhibitors with ferroptosis inducers for treating this type of cancer.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
